Skip to main content
EnglishEnglish
EnglishEnglishArabicArabicChinese (Simplified)Chinese (Simplified)FrenchFrenchGermanGermanHindiHindiPortuguesePortugueseRussianRussianSpanishSpanishSwahiliSwahili

Header

  • Contact us
  • Subscribe to newsletter
Home The Task Force for Global Health logo
  • https://twitter.com/GlobalHep
  • https://www.facebook.com/GlobalHep/
  • https://vimeo.com/globalhep
Donate
Add a Program
Add a Program
Profile
Logout

Main navigation

  • About
    • Who we are
    • What we do
    • Our team
    • Technical Advisory Board
    • Executive Board
    • Donor Acknowledgements
    • CGHE Annual Reports
      • Annual Report 2021
      • Annual Report 2020
  • Programs
    • Programs search
  • Data dashboards
    • Country data dashboards
    • National Hepatitis Elimination Profiles
  • Evidence base
    • All evidence (search)
      • Evidence Base Methodology
    • HCV Treatment in Pregnancy
    • Action Plan Systematic Review
    • Hepatitis B Birth Dose Vaccine Systematic Review
      • Synthesis Brief of Hepatitis B Birth Dose Evidence Base
    • HCV Testing Systematic Review
    • COVID-19 Evidence Hub
      • COVID-19 and Liver Disease Synthesis
      • Clinical Liver Disease COVID-19 special series
        • The COVID-19 Pandemic: An Epidemiologic, Public Health, and Clinical Brief
        • Synthesis of Liver Associations Recommendations for Hepatology and Liver Transplant Care During the COVID-19 Pandemic
    • Innovations in Hepatitis Elimination (CLD Series)
      • Author Interviews
      • Introduction to Series
      • Past Publications
      • Author Guidance
    • Hepatitis Elimination Help Desk
  • Resources
    • Search resources
    • Technical Assistance Help Desk and Frequently Asked Questions
  • Webinars
    • Hep Test
    • Linkage to care
    • Strategic Information Collaborative
    • Regional Hepatitis Elimination
    • HepB Birth Dose Introduction in AFRO
    • Innovations in Hepatitis Elimination
    • NIH Research Advancing Hepatitis Elimination
    • Search webinars
  • Elimination champions
    • Elimination Champions
    • Nominations for Elimination Champions
  • News
    • News search
  • Hep C Elimination Tool
    • Access the Tool
    • User Guide
    • Frequently Asked Questions
  1. Home
  2. Resources
  3. Resources search

Resources search

Filter

  • Hepatitis B
  • Hepatitis C
  • Data
  • Guidelines
  • Implementation
  • National plans
  • Policy
  • Program evaluation
  • HCV testing and linkage to Care
  • HCV treatment
  • Hep B birth-dose vaccination
  • Persons who inject drugs: HCV cure as prevention
  • Persons who inject drugs: Medication assisted therapy
  • Prevention mother-child transmission
  • Strategic data analysis
  • Albania
  • Algeria
  • Andorra
  • Argentina
  • Armenia
  • Australia
  • Austria
  • Azerbaijan
  • Bangladesh
  • Belarus
  • Belgium
  • Bosnia and Herzegovina
  • Brazil
  • Bulgaria
  • Cameroon
  • China
  • Congo (Democratic Republic of the)
  • Croatia
  • Cyprus
  • Czech Republic
  • Denmark
  • Egypt
  • Estonia
  • Ethiopia
  • Fiji
  • Finland
  • France
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Global
  • Greece
  • Hong Kong
  • Hungary
  • Iceland
  • India
  • Iraq
  • Ireland
  • Israel
  • Italy
  • Japan
  • Kazakhstan
  • Kiribati
  • Kyrgyzstan
  • Latvia
  • Libya
  • Lithuania
  • Luxembourg
  • Macedonia (the former Yugoslav Republic of)
  • Malaysia
  • Malta
  • Mauritania
  • Mexico
  • Moldova (Republic of)
  • Monaco
  • Mongolia
  • Montenegro
  • Morocco
  • Myanmar
  • Netherlands
  • New Zealand
  • Nigeria
  • Norway
  • Pakistan
  • Papua New Guinea
  • Philippines
  • Poland
  • Portugal
  • Romania
  • (-) Russian Federation
  • Rwanda
  • San Marino
  • Saudi Arabia
  • Serbia
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • Spain
  • Sudan
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • Taiwan
  • Tajikistan
  • Tanzania
  • Thailand
  • Tonga
  • Turkey
  • Turkmenistan
  • Uganda
  • Ukraine
  • United Kingdom
  • United States of America
  • Uzbekistan
  • Vanuatu
  • Viet Nam
  • Yemen

Displaying 1 - 11 of 11

  • Policy

    The 2016 Hep-CORE Report: Monitoring the implementation of hepatitis B and C policy recommendations in Europe

    23 Apr 2016
    ELPA
    Hepatitis B
    Hepatitis C
  • Program evaluation

    Accelerating access to hepatitis C diagnostics and treatment: Overcoming barriers in low- and middle-income countries

    27 Jan 2021
    World Health Organization
    Hepatitis C
  • Policy

    Do the most heavily burdened countries have the right policies to eliminate viral hepatitis B and C?

    27 Jul 2020
    Palayew A et al. Lancet Gastro Hep.
    Hepatitis B
    Hepatitis C
  • Data

    Hepatitis C in the Russian Federation: challenges and future directions

    05 May 2016
    NCBI
    Hepatitis C
  • Data

    Hepatitis C virus infection, HIV co-infection, and associated risk among injecting drug users in Togliatti, Russia

    01 Nov 2005
    International Journal of STD & AIDS
    Hepatitis C
  • Data

    Hepatitis C virus infection among drug injectors in St Petersburg, Russia: social and molecular epidemiology of an endemic infection

    09 Oct 2009
    Society for the Study of Addiction
    Hepatitis C
  • Data

    Prevalence of HIV, hepatitis C and syphilis among injecting drug users in Russia: a multi‐city study

    24 Jan 2006
    Society for the Study of Addiction
    Hepatitis C
  • Program evaluation

    Impact of Universal Hepatitis B Vaccination on Prevalence, Infection-Associated Morbidity and Mortality, and Circulation of Immune Escape Variants in Russia

    09 Jun 2016
    NCBI
    Hepatitis B
  • National plans

    Action plan for the health sector response to viral hepatitis in the WHO European Region

    03 Apr 2017
    WHO EURO Region
    Hepatitis B
    Hepatitis C
  • Guidelines

    Hepatitis C Elimination in Europe European Policy Guidelines

    01 Nov 2017
    Hepatitis B and C Public Policy Association
    Hepatitis C
  • Implementation

    Prevention and control of Viral Hepatitis in the Russian Federation: lessons learnt and the way forward

    26 Oct 2018
    Hepatitis B
    Hepatitis C

Contact us

globalhep [at] taskforce.org

Tel: +1-404-371-0466

 

Photos on home page by Tayvessa Wilson, Conor Ashleigh, and Zunaid Murshed Paiker

Support us

Donate

Follow us

  • https://twitter.com/GlobalHep
  • https://www.facebook.com/GlobalHep/
  • https://vimeo.com/globalhep

Sign up to our newsletter

<

Footer

  • Contact
© 2019 - 2022 Coalition for Global Hepatitis Elimination
Website by Manta Ray Media